ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2026
Management of pedıatrıc Candıda central nervous system ınfectıons: a retrospectıve analysıs of a challengıng case serıes.
Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCentral nervous system (CNS) infections caused by Candida species are serious clinical conditions associated with high morbidity and mortality, especially in children with neurosurgical devices. The aim of this study is to evaluate the clinical characteristics, changing microbiological profile, and treatment outcomes of pediatric Candida meningitis/ventriculitis cases followed in our center.
methodsTwenty-five pediatric patients followed at a tertiary referral center, with Candida growth in CSF or shunt culture between August 2018 and September 2025 were analyzed retrospectively. Demographic data, associated clinical characteristics, CSF findings, isolated species, and treatment approaches were analyzed.
resultsThe median age of the patients was 16.7 months (range 3.7-144), and 84% (n = 21) had a history of ventriculoperitoneal (VP) shunt. Prior broad-spectrum antibiotic use and history of neurosurgical intervention were detected in all patients (100%). CSF analysis revealed markedly elevated protein levels (median 294 mg/dL). Although Candida spp. (76%) was the leading isolate, Candida auris, considered a global threat, was detected in one case. Concomitant bacterial infection was observed in 68% of the cases. The median length of hospital stay was 60 days, and the mortality rate was 12%. Treatment failure was observed in cases where the shunt was not removed, whereas cure was achieved in patients who underwent shunt revision and systemic antifungal therapy.
conclusionThe presence of a VP shunt and intensive antibiotic use are the primary predisposing factors for pediatric fungal CNS infections. The emergence of resistant species such as C. auris in childhood complicates treatment strategies. Immediate removal of the shunt and aggressive antifungal therapy targeted at the agent are essential for successful management.
Indexed as
Identifiers
41879889What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.